Literature DB >> 8668794

Optimal placement of radioisotopes for permanent prostate implants.

V Narayana1, P L Roberson, R J Winfield, M L Kessler, P W McLaughlin.   

Abstract

PURPOSE: To determine which of four loading techniques most efficiently yields the prescribed dose to the prostate volume while limiting dose to the central urethral volume.
MATERIALS AND METHODS: The four techniques included (a) equal activity and equal spacing with nomogram, (b) differential loading, (c) peripheral loading, and (d) spiked loading of the lobes. They were evaluated with regard to target coverage urethra dose, tolerance to error, and complexity of procedure.
RESULTS: All ideal plans delivered the prescribed dose of 160 Gy to 99% of the prostate volume. With prostate-volume expansion and source-placement errors, all strategies indicated that at least 71% of the target volume received the prescribed dose and greater than 92% of the target volume received 120 Gy.
CONCLUSION: With source-placement errors and glandular swelling, peripheral loading yields the best target coverage while limiting dose to the central urethral volume.

Mesh:

Substances:

Year:  1996        PMID: 8668794     DOI: 10.1148/radiology.199.2.8668794

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  3 in total

1.  Robust path planning for flexible needle insertion using Markov decision processes.

Authors:  Xiaoyu Tan; Pengqian Yu; Kah-Bin Lim; Chee-Kong Chui
Journal:  Int J Comput Assist Radiol Surg       Date:  2018-05-11       Impact factor: 2.924

2.  Embolization of prostatic brachytherapy seeds to pulmonary arteries: a case study.

Authors:  Alexander D Calvert; Andrew W Dyer; Van A Montgomery
Journal:  Radiol Case Rep       Date:  2016-11-12

3.  Accuracy evaluation of a 3D-printed individual template for needle guidance in head and neck brachytherapy.

Authors:  Ming-Wei Huang; Jian-Guo Zhang; Lei Zheng; Shu-Ming Liu; Guang-Yan Yu
Journal:  J Radiat Res       Date:  2016-07-15       Impact factor: 2.724

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.